Anti-Angiogenic Activity of Flunarizine by In Ovo, In Vitro, and In Vivo Assays

Journal Title: Turkish Journal of Pharmaceutical Sciences - Year 2019, Vol 16, Issue 3

Abstract

Objectives: The involvement of T-type calcium channels in cell proliferation and the role of sodium channels in cell migration have been extensively studied in angiogenesis. In the present study, flunarizine, a dual sodium/calcium channel blocker; was selected to evaluate its anti-angiogenic potential. This can be therapeutically beneficial in diseases caused by pathologically excessive angiogenesis. Materials and Methods: The anti-angiogenic activity of ion channel blocker was screened by chick chorioallantoic membrane assay (in ovo), rat aortic ring assay, endothelial cell proliferation assay, transwell migration assay, Matrigel cord-like morphogenesis assay (in vitro), and sponge implantation method (in vivo). The anti-angiogenic activity of the test drug was compared with the standard anti-angiogenic drug bevacizumab and, in addition, the test responses were compared with the angiogenic factor vascular endothelial growth factor at a maximal concentration of 500 pM. Results: All the groups were compared with the control group using one-way ANOVA, followed by a post hoc test, Dunnett’s test, to compare the mean of all the groups with the control mean. In the chick chorioallantoic membrane assay, the number of branching points and angiogenic score were evaluated and significant results were observed at 10-5 M and 10-4 M. In the aortic ring assay a reduction in the area of sprouts was observed with 5-10 μM and significant reductions in the weight of sponges, number of blood vessels formed, and hemoglobin content were observed at all three tested concentrations of flunarizine in the sponge implantation method. In the studies on human umbilical vein endothelial cells the test drug (1-100 nM) showed significant inhibition of proliferation and migration and a decrease in the network length of cord-like tubes in a dose-dependent manner. Conclusion: Flunarizine has significant anti-angiogenic action by inhibiting cell proliferation, migration, and cord-like tube formation, which resulted from blocking of the T-type calcium and sodium channels. Further studies on the structural modifications of flunarizine for repurposing this ion channel modulator will lead to treatment of the diseases due to excessive angiogenesis from the root cause.

Authors and Affiliations

Chandana KAMILI, Ravi Shankar KAKARAPARTHY, Uma Maheshwararao VATTIKUTI

Keywords

Related Articles

In Vivo Effects of Naringenin and Lead on Rat Erythrocyte Carbonic Anhydrase Enzyme

Objectives: Carbonic anhydrase (CA) enzyme catalyses the reversible reactions of CO2 with water and takes part in metabolically important events such as systemic acid-base regulation and respiration. In this study, in vi...

Development and Pre-clinical Study of Anti-Allergic Cream Containing Dexamethasone and Chlorpheniramine

Objectives: In this study, we aimed to develop and optimize an anti-allergic cream containing dexamethasone and chlorpheniramine using the design of experiments (DoE) method. The optimized product was investigated for it...

The Effect of Sumatriptan in Ischemic Conditions in the Rat Heart

Objectives: The aim of this study was to investigate the effect of SUM on IR-induced injury in rat heart and its effect on IPC-induced protection. Materials and Methods: The rats were randomly divided into four groups: I...

Adenosine A2B Receptors - Mediated Induction of Interleukin-6 in Skeletal Muscle Cells

Objectives: Inflammatory response and cytokine activation are markedly stimulated in skeletal muscle during various conditions. Interleukin-6 (IL-6), a pro-inflammatory cytokine, has pleiotropic effects on skeletal muscl...

Phytochemical Screening and Toxicological Evaluation of Sargassum wightii Greville in Wistar Rats

Objectives: The present study was conducted to identify the phytoconstituents present in different extracts of Sargassum wightii and to assess the toxicity of its ethanol extract. Materials and Methods: Successive solven...

Download PDF file
  • EP ID EP604407
  • DOI 10.4274/tjps.galenos.2018.29981
  • Views 150
  • Downloads 0

How To Cite

Chandana KAMILI, Ravi Shankar KAKARAPARTHY, Uma Maheshwararao VATTIKUTI (2019). Anti-Angiogenic Activity of Flunarizine by In Ovo, In Vitro, and In Vivo Assays. Turkish Journal of Pharmaceutical Sciences, 16(3), 303-309. https://europub.co.uk/articles/-A-604407